Analysis of gene expression differences pre- and post-lytic reactivation of Epstein-Barr virus in Burkitt's lymphoma

被引：0
作者：
Gong, Zhiyuan [1 ]
Liu, Wen [1 ]
Luo, Bing [1 ]
机构：
[1] Qingdao Univ, Sch Basic Med, Dept Pathogen Biol, Qingdao 266071, Peoples R China
来源：
FUTURE VIROLOGY | 2024年 / 19卷 / 6-7期
关键词：
Burkitt's lymphoma; Epstein-Barr virus; lytic reactivation; sodium butyrate; VARIANTS; PROGRAM; LATENCY;
D O I：
10.1080/17460794.2024.2360830
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Aim: This study explores changes in viral and host gene expressions during Epstein-Barr virus lytic reactivation, establishing a bioinformatics foundation for understanding the pathogenesis of Burkitt's lymphoma (BL) and identifying potential therapeutic targets. Methods: We used the data set GSE141220 to assess differentially expressed genes. Subsequent analyses included Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment. Hub genes were identified using Cytoscape. Results: Viral gene expression exhibited significant alterations 24 h after treatment with Sodium butyrate (NaB). Upregulated host genes mainly related to the PI3K-Akt and MAPK signaling pathways. Conclusion: Epstein-Barr virus lytic reactivation is likely to involve the activation of the PI3K-Akt and MAPK signaling pathways. Hub genes may serve as therapeutic targets for BL.
引用
收藏
页码：229 / 237
页数：9
相关论文
共 50 条
  • [21] Latent and Lytic Epstein-Barr Virus Gene Expression in the Peripheral Blood of Astronauts
    Stowe, Raymond P.
    Kozlova, Elena V.
    Sams, Clarence F.
    Pierson, Duane L.
    Walling, Dennis M.
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (06) : 1071 - 1077
  • [22] Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels
    Phan, An T.
    Fernandez, Samantha G.
    Somberg, Jessica J.
    Keck, Kristin M.
    Miranda, J. J. L.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 474 (01) : 71 - 75
  • [23] Epstein-Barr virus expression in Hodgkin's lymphoma in Kuwait
    Makar, RR
    Saji, T
    Junaid, TA
    PATHOLOGY & ONCOLOGY RESEARCH, 2003, 9 (03) : 159 - 165
  • [24] Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
    Anderson, Abbie G.
    Gaffy, Cullen B.
    Weseli, Joshua R.
    Gorres, Kelly L.
    VIRUSES-BASEL, 2019, 11 (05):
  • [25] Pediatric Burkitt lymphoma with concurrent chronic Epstein-Barr virus hepatitis
    Preciado, MV
    De Matteo, E
    Freigeiro, D
    Galoppo, C
    Saúl, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 33 (02): : 134 - 136
  • [26] Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi
    Xue, SA
    Labrecque, LG
    Lu, QL
    Ong, SK
    Lampert, IA
    Kazembe, P
    Molyneux, E
    Broadhead, RL
    Borgstein, E
    Griffin, BE
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (05) : 635 - 643
  • [27] Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil
    Klumb, CE
    Hassan, R
    De Oliveira, DE
    De Resende, LMM
    Carriço, MK
    Dobbin, JD
    Pombo-de-Oliveira, MS
    Bacchi, CE
    Maia, RC
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (01) : 66 - 70
  • [28] Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production
    Lee, Jaeyeun
    Kosowicz, John G.
    Hayward, S. Diane
    Desai, Prashant
    Stone, Jennifer
    Lee, Jae Myun
    Liu, Jun O.
    Ambinder, Richard F.
    JOURNAL OF VIROLOGY, 2019, 93 (20)
  • [29] IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells
    Gao, Ying
    Wang, Liu
    Lei, Zhangmengxue
    Li, Jie
    Forrest, J. Craig
    Liang, Xiaozhen
    JOURNAL OF GENERAL VIROLOGY, 2019, 100 (05) : 851 - 862
  • [30] High susceptibility of an Epstein-Barr virus-converted Burkitt's lymphoma cell line to cytotoxic drugs
    Okano, M
    LEUKEMIA RESEARCH, 1997, 21 (05) : 469 - 471
12345